From Financialpost · · 1m 20s
BAM Welcomes New Board Members
Bioscience Association Manitoba appoints new board and executive leaders after annual meeting.
In brief
Bioscience Association Manitoba appoints new board and executive leaders after annual meeting. Bioscience Association Manitoba appointed new board members and executives to strengthen Manitoba's bioscience ecosystem. Originally reported by Financialpost.
New Board Appointments
Bioscience Association Manitoba announced new board and executive members following its October 15, 2026 annual general meeting.
New Board Members
Brad Elias from Winnipeg Airports Authority, Heather Berthelette from Spirit Healthcare Group, Henry Floreal from Taumedis, Ian Robertson from GlaxoSmithKline, James Willis from Baxter Corporation, and Dr. Sarah Dentry from CancerCare Manitoba joined the board.
New Executive Board
Dvorah Richler of Emergent BioSolutions serves as chair, Martin Barbeau of Bausch Health Canada as vice-chair, Will Kaye of MNP LLP as treasurer, and Kyle Brown of Moderna Canada as secretary.
Leadership Statement
Andrea Ladouceur, President & CEO of BAM, said new directors bring knowledge, experience, and perspectives to strengthen Manitoba's bioscience industry.
Outgoing Board Thanks
BAM thanked outgoing board members for their leadership and contributions to advancing the organization's mandate.
Outgoing Board Member Reflection
Reuben Saba, Past Board Chair, praised the work of BAM and confidence in the incoming board to create new opportunities for the sector.
Future Focus
The new board will support BAM's work to connect Manitoba's bioscience community and advocate for sector growth.
The essence
Bioscience Association Manitoba appointed new board members and executives to strengthen Manitoba's bioscience ecosystem.
